Business Context and Reporting Period
Company: GlaxoSmithKline plc (GSK)
Filing Type: Form 6-K (Report of Foreign Issuer)
Reporting Period: March 26, 2014
Context: This filing announces the publication of the 2014 Notice of Annual General Meeting (AGM) and provides logistical details for the upcoming shareholder meeting.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document serves solely as a corporate governance notice regarding the AGM and does not contain financial performance data.
Material Changes
No material financial changes versus the prior comparable period are reported in this filing. The document focuses exclusively on the scheduling and distribution of the 2014 AGM Notice.
Guidance, Outlook, and Management Commentary
- AGM Schedule: The Annual General Meeting is scheduled for Wednesday, May 7, 2014, at 2:30 pm.
- Location: Queen Elizabeth II Conference Centre, Broad Sanctuary, Westminster, London, SW1P 3EE.
- Document Availability: The 2014 AGM Notice is available on the company website. Hard copies, along with the 2013 Annual Report, are being mailed to shareholders who elected paper communications.
- Regulatory Compliance: The notice is being submitted to the UK Listing Authority in compliance with Listing Rule 9.6.1 of the UK Financial Conduct Authority (FCA) and will be available for inspection via the Morningstar UK website.
Investor Verification Checklist
- Verify the date and location of the 2014 Annual General Meeting (May 7, 2014, London).
- Confirm receipt of the 2014 AGM Notice and the 2013 Annual Report if paper communications were elected.
- Review the 2013 Annual Report (referenced in this filing) for detailed financial performance data, as this Form 6-K does not contain financial statements.
- Check the company website (www.gsk.com) for the digital version of the AGM Notice.